Cheng Gao

593 total citations
31 papers, 430 citations indexed

About

Cheng Gao is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Cheng Gao has authored 31 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 9 papers in Cancer Research and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Cheng Gao's work include Cancer-related molecular mechanisms research (8 papers), RNA modifications and cancer (6 papers) and Epigenetics and DNA Methylation (4 papers). Cheng Gao is often cited by papers focused on Cancer-related molecular mechanisms research (8 papers), RNA modifications and cancer (6 papers) and Epigenetics and DNA Methylation (4 papers). Cheng Gao collaborates with scholars based in China, United States and Canada. Cheng Gao's co-authors include Lizong Shen, Shoulin Wang, Liuhua Wang, Zhihong Zhang, Ruqian Zhao, Weijuan Shao, Jianfei Wen, Weiming Zhang, Guoxin Zhang and Weimin Li and has published in prestigious journals such as Oncogene, FEBS Letters and Frontiers in Immunology.

In The Last Decade

Cheng Gao

29 papers receiving 427 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cheng Gao China 12 192 141 85 75 52 31 430
Fátima Guerrero Spain 14 206 1.1× 84 0.6× 49 0.6× 83 1.1× 41 0.8× 28 784
Nabil A. Rashdan United States 13 197 1.0× 65 0.5× 48 0.6× 58 0.8× 25 0.5× 18 460
Yilun Deng United States 11 85 0.4× 135 1.0× 131 1.5× 40 0.5× 79 1.5× 29 417
Mary C. Wallingford United States 13 207 1.1× 79 0.6× 50 0.6× 77 1.0× 22 0.4× 26 519
Luqian Zhao China 11 209 1.1× 134 1.0× 186 2.2× 38 0.5× 55 1.1× 14 573
Yanhua Li China 15 345 1.8× 66 0.5× 178 2.1× 47 0.6× 42 0.8× 33 625
Andrea Grund Germany 13 231 1.2× 78 0.6× 47 0.6× 40 0.5× 38 0.7× 17 458
Chia-Lo Chang Taiwan 9 119 0.6× 120 0.9× 43 0.5× 42 0.6× 31 0.6× 9 377
Ming‐Zhi Zhang United States 12 180 0.9× 47 0.3× 38 0.4× 62 0.8× 37 0.7× 26 478
Akashi Taguchi Japan 7 254 1.3× 40 0.3× 126 1.5× 29 0.4× 35 0.7× 11 406

Countries citing papers authored by Cheng Gao

Since Specialization
Citations

This map shows the geographic impact of Cheng Gao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng Gao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng Gao more than expected).

Fields of papers citing papers by Cheng Gao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng Gao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng Gao. The network helps show where Cheng Gao may publish in the future.

Co-authorship network of co-authors of Cheng Gao

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng Gao. A scholar is included among the top collaborators of Cheng Gao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng Gao. Cheng Gao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Peng, Zhenwei Han, Tianxin Xu, et al.. (2025). ALG3 as a prognostic biomarker and mediator of PD-1 blockade resistance in hepatocellular carcinoma. Frontiers in Immunology. 16. 1589153–1589153. 1 indexed citations
2.
Chen, Chen, Ning Wang, Tingting Huang, et al.. (2023). Chloroprocaine antagonizes progression of breast cancer by regulating LINC00494/miR‐3619‐5p/MED19 axis. Journal of Biochemical and Molecular Toxicology. 38(1). e23524–e23524. 3 indexed citations
3.
Gao, Cheng, et al.. (2023). AKR1C1 overexpression leads to lenvatinib resistance in hepatocellular carcinoma. Journal of Gastrointestinal Oncology. 14(3). 1412–1433. 6 indexed citations
4.
Zhang, Yu, Weipeng Chen, Xin Cheng, et al.. (2022). Sphingomyelin Phodiesterase Acid-Like 3A Promotes Hepatocellular Carcinoma Growth Through the Enhancer of Rudimentary Homolog. Frontiers in Oncology. 12. 852765–852765. 10 indexed citations
5.
Chen, Weipeng, et al.. (2021). The expression and prognostic value of REXO4 in hepatocellular carcinoma. Journal of Gastrointestinal Oncology. 12(4). 1704–1717. 3 indexed citations
6.
Gao, Cheng, et al.. (2021). Knockdown of lncRNA LINC00707 alleviates LPS-induced injury in MRC-5 cells by acting as a ceRNA of miR-223-5p. Bioscience Biotechnology and Biochemistry. 85(2). 315–323. 9 indexed citations
7.
Gao, Cheng, et al.. (2021). Low expression of AQP9 and its value in hepatocellular carcinoma. Translational Cancer Research. 10(4). 1826–1841. 6 indexed citations
8.
Gao, Cheng, et al.. (2021). NEAT1 Boosts the Development of Thoracic Aortic Aneurysm Through Targeting miR-324-5p/RAN. Archives of Medical Research. 53(1). 93–99. 4 indexed citations
9.
Liu, Min, Cheng Gao, Xiying Chen, et al.. (2021). Centrosomal protein FOR20 knockout mice display embryonic lethality and left‐right patterning defects. FEBS Letters. 595(10). 1462–1472. 2 indexed citations
10.
Cheng, Xin, Yu Zhang, Fei Song, et al.. (2020). <p>URM1 Promoted Tumor Growth and Suppressed Apoptosis via the JNK Signaling Pathway in Hepatocellular Carcinoma</p>. OncoTargets and Therapy. Volume 13. 8011–8025. 6 indexed citations
12.
Gao, Cheng, et al.. (2019). Long non-coding RNA SNHG17 promotes gastric cancer progression by inhibiting P15 and P16. Translational Cancer Research. 8(2). 520–531. 1 indexed citations
14.
Gao, Cheng, Liuhua Wang, Guoxin Zhang, et al.. (2018). Involvement of Aryl Hydrocarbon Receptor and Aryl Hydrocarbon Receptor Repressor in Helicobacter Pylori-related Gastric Pathogenesis. Journal of Cancer. 9(15). 2757–2764. 11 indexed citations
15.
Wang, Liuhua, et al.. (2018). Application of enhanced recovery after gastric cancer surgery: An updated meta-analysis. World Journal of Gastroenterology. 24(14). 1562–1578. 64 indexed citations
16.
Gao, Cheng. (2013). Establishment of a Microtus fortis model of non-alcoholic fatty liver. 1 indexed citations
17.
Wang, Chunlei, Xiaofeng Chen, Jianing Wu, et al.. (2013). Low-dose arsenic trioxide enhances 5-aminolevulinic acid-induced PpIX accumulation and efficacy of photodynamic therapy in human glioma. Journal of Photochemistry and Photobiology B Biology. 127. 61–67. 11 indexed citations
18.
Lin, Jinxing, et al.. (2012). Fine Structure, Enzyme Histochemistry, and Immunohistochemistry of Liver in Zebrafish. The Anatomical Record. 295(4). 567–576. 36 indexed citations
19.
Sun, Zhe, et al.. (2008). Recombinant hirudin treatment modulates aquaporin-4 and aquaporin-9 expression after intracerebral hemorrhage in vivo. Molecular Biology Reports. 36(5). 1119–1127. 39 indexed citations
20.
Shao, Weijuan, et al.. (2007). Exposure of preimplantation embryos to insulin alters expression of imprinted genes.. PubMed. 57(5). 482–6. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026